LIGACHEM Trademark
Trademark Overview
On Friday, September 6, 2024, a trademark application was filed for LIGACHEM with the United States Patent and Trademark Office. The USPTO has given the LIGACHEM trademark a serial number of 79410373. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 21, 2024. This trademark is owned by LigaChem Biosciences Inc.. The LIGACHEM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Research and development of vaccines and medicines; biomedical research services; biological research and analysis; medical research in the field of crude drugs; biochemical research and analysis; bacteriological research and analysis; drug discovery services; research and development of medicines; biotechnology research; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; laboratory research in the field of pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical drug development services; consultancy pertaining to pharmacology; research in the field of pharmaceuticals; scientific research for medical purposes in the field of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical research services; medical research laboratory services; research of...
General Information
Serial Number | 79410373 |
Word Mark | LIGACHEM |
Filing Date | Friday, September 6, 2024 |
Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
Status Date | Thursday, November 21, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Research and development of vaccines and medicines; biomedical research services; biological research and analysis; medical research in the field of crude drugs; biochemical research and analysis; bacteriological research and analysis; drug discovery services; research and development of medicines; biotechnology research; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; laboratory research in the field of pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical drug development services; consultancy pertaining to pharmacology; research in the field of pharmaceuticals; scientific research for medical purposes in the field of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical research services; medical research laboratory services; research of medicines; platform as a service (PAAS) featuring computer software platforms for research and development in the field of pharmaceuticals, biotechnology and medicine; laboratory research services relating to pharmaceuticals; research services in the field of pharmaceutical preparations; testing of pharmaceuticals; clinical research in the field of medicine; chemical research and analysis. |
Classification Information
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, December 2, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | LigaChem Biosciences Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | KR |
Trademark Events
Event Date | Event Description |
Thursday, November 21, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Monday, December 2, 2024 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
Thursday, December 5, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, December 5, 2024 | APPLICATION FILING RECEIPT MAILED |